New Search

If you are not happy with the results below please do another search

Generic filters

50 search results for:


How Biotech Saved the World: Pfizer CEO Opens Up and Shares What’s Next

A sense of urgency, powerful science, relentless ingenuity, hope and trust drove the development of Pfizer and BioNTech’s mRNA vaccine during the height of the Covid-19 pandemic. As the crisis appears to lessen, Pfizer is preparing for the next pandemic.


AstraZeneca antibody cocktail fails to prevent Covid-19 symptoms in large trial

AstraZeneca said a late-stage trial failed to provide evidence that the company’s Covid-19 antibody therapy protected people who had contact with an infected person from the disease, a small setback in its efforts to find alternatives to vaccines.


FCB Health New York & Broadcast Journalist Ted Koppel Team Up To Find The Millions Living With Undiagnosed COPD 

FCB Health New York teamed up with broadcast journalist Ted Koppel and his wife, COPD activist Grace Anne Dorney Koppel, to help find the millions of people living with undiagnosed chronic obstructive pulmonary disease. The COVID-19 pandemic has worsened the crisis, leaving those with COPD particularly vulnerable, and the “COPD SOS” campaign urges diagnosis and vaccination.


PRECISIONscientia Earns a Philadelphia Business Journal’s Best Places to Work Honor for Second Consecutive Year

PRECISIONscientia announced the Pennsylvania-based full-service medical communications agency is an honoree in the Philadelphia Business Journal’s 2021 Best Places to Work Awards in the large company category. Voted by the people who know them best—its employees—the award celebrates the top companies in the Greater Philadelphia area. This marks the second consecutive year that PRECISIONscientia made the annual list.


As death rate slows, U.S. exceeds 600,000 Covid-19 fatalities

The United States on June 14 crossed the grim milestone of 600,000 Covid-19 deaths, according to a Reuters tally, as slowing vaccination rates threaten the Biden administration target of having 70 percent of U.S. adults receive at least one shot and 160 million fully inoculated by July 4.